Fludarabine, Busulfan, Thymoglobulin

DRUG3 trials

Sponsors

University Hospital, Clermont-Ferrand, The Korean Society of Pediatric Hematology Oncology

Conditions

Acute Myeloid LeukemiaHematologic NeoplasmsSolid TumorsWiskott-Aldrich Syndrome

Phase 1

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)

CompletedNCT00885833

The Korean Society of Pediatric Hematology OncologyWiskott-Aldrich Syndrome

Start: 2007-02-28End: 2012-03-31Target: 5Updated: 2014-07-14

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

The Korean Society of Pediatric Hematology OncologyAcute Myeloid Leukemia

Start: 2006-06-30End: 2012-05-31Target: 35Updated: 2012-03-26

Phase 2

Allogeneic Hematopoietic Stem Cell Transplantation

University Hospital, Clermont-FerrandHematologic Neoplasms, Solid Tumors

Start: 2007-04-30End: 2009-04-30Target: 30Updated: 2011-01-19